The lung immune prognostic index as a predictive biomarker in urological malignancies undergoing immune checkpoint inhibitor therapy

Objective We conducted a meta-analysis to evaluate the prognostic utility of the Lung Immune Prognostic Index (LIPI) in patients with urological malignancies treated with immune checkpoint inhibitors (ICIs).Methods We systematically searched PubMed, the Cochrane Library, and EMBASE up to March 3, 20...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yan He, Yuan Yuan, Xiao Wei, Lili Li, Pengcheng Luo
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Taylor & Francis Group 2025-12-01
Sarja:	Annals of Medicine
Aiheet:	Lung Immune Prognostic index (LIPI) immune checkpoint inhibitors (ICIs) urological malignancies meta-analyses
Linkit:	https://www.tandfonline.com/doi/10.1080/07853890.2025.2582907
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!